Clin2
NCT07323446Possibly a fitNot yet recruiting

NAC supplement for emotional regulation in children

Emotional Dysregulation

Treatments studied

Part of Mental health clinical trials.

This study tests whether a supplement called N-acetylcysteine (NAC) can help children aged 6-12 who have intense emotions and mood swings. It also looks at brain activity before and after treatment to see if NAC might improve emotional control.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
120 people
Ages
6 years to 12 years
Study type
Interventional

Who can take part

  • The child must be between 6 and 12 years old.
  • The child must have significant emotional and behavioral challenges, like frequent mood swings or intense anger.
  • The child must not have serious medical conditions, such as heart, liver, or kidney disease, or a history of seizures.
  • A parent or guardian must be able to provide written consent, and the child must agree to participate.
  • Families need access to a computer with a camera, speaker, microphone, and internet.
  • The child must be willing to avoid changes in their current treatments during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07464886Recruiting· Phase 3
NAC and mindfulness therapy for depression in youth

This study tests whether a supplement called N-acetylcysteine (NAC) combined with a type of therapy called Mindfulness-Based Cognitive Therapy (MBCT) can help improve depression in teenagers and young adults. It looks at how these treatments affect brain chemicals and may reduce symptoms.

Cincinnati, Ohio
NCT05664789Recruiting· Phase 2/Phase 3
N-acetylcysteine for autism behaviors in children

This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.

Palo Alto, California
NCT05494398Enrolling by invitation· Phase 2/Phase 3
Testing N-acetylcysteine for autism symptoms

This study looks at whether N-acetylcysteine (NAC), a supplement/medication, can help autism-related symptoms by trying to target brain chemistry. You may be able to join if you previously took part in a related NAC study and can keep your usual medications steady.

Stanford, California
NCT04381897Not yet recruiting· Phase 2
NAC treatment for repetitive behaviors in Cornelia de Lange syndrome

This study tests whether N-acetylcysteine (a supplement) can reduce repetitive or self-injurious behaviors in people with Cornelia de Lange syndrome. It involves 4 hospital visits over 18 weeks.

Baltimore, Maryland
NCT04278898Recruiting· Phase 2
N-acetylcysteine to reduce repetitive behaviors in children with autism

This Phase 2 study tests whether a single dose of N-acetylcysteine can improve “restricted and repetitive behaviors” in children with autism. It’s meant for kids who are stable and still in early puberty stages.

Stanford, California
NCT05142735Recruiting
NAC for early psychosis risk symptoms

This trial studies whether NAC (a nutrient-like supplement) can reduce symptoms in people who are at high risk for developing psychosis. It may help by testing a safer, non-standard treatment approach for early warning signs.

Toronto, Ontario

Hear when a new Emotional Dysregulation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.